Volume : 08, Issue : 08, August – 2021

Title:

18.OVERVIEW OF NEUROPATHIC PAIN AND ITS OUTPATIENT MANAGEMENT

Authors :

Yasir Hameed Albeladi, Saad Ali Alghamdi, Farouq Abdullah Hassan Alghamdi

Abstract :

Patients with neuropathic pain syndrome often express a range of sensory signs and symptoms. The spectrum of these symptoms consists of “painless” to “painless but debilitating” to “painful”. It is characterized by the unusual sensitivity of nociceptive receptors to stimuli (hyperalgesia) with resultant hyperstimulation of the sensory nervous system (allodynia). Stimulation of nociceptor unit receptors, with stimuli-provoked impulse generation that can be spatially and/or temporally summated through its transmission, is likely the causative mechanism of the symptoms patients usually suffer from. It is imperative to reach an exact diagnosis and to explore the pathophysiology of each patient; only when this has been achieved then is it possible to plan adequate symptom-oriented therapeutic strategies. Numerous interventions for neuropathic pain are available, but its treatment remains unsatisfactory. The available treatments mostly have modest efficacy and come with side effects that limit their use whereas some newer therapeutic approaches are preferred for outpatient management.
Aim: In this review article, we will discuss an overview of neuropathic pain and its classification and pathophysiology, in addition to the treatment algorithm used for outpatients.
Keywords: Neuropathic, pain, trigeminal neuralgia, post-herpetic neuralgia, gabapentin.

Cite This Article:

Please cite this article in press Hema V. Badgujar et al., Overview Of Neuropathic Pain And Its Outpatient Management.., Indo Am. J. P. Sci, 2021; 08(08).

Number of Downloads : 10

References:

1. Cavalli E, Mammana S, Nicoletti F, Bramanti P, Mazzon E. The neuropathic pain: An overview of the current treatment and future therapeutic approaches. Int J Immunopathol Pharmacol. 2019;33:2058738419838383.
2. van Hecke O, Austin SK, Khan RA, Smith BH, Torrance N. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain. 2014;155(4):654-62.
3. Sneddon LU. Pain in aquatic animals. J Exp Biol. 2015;218(Pt 7):967-76.
4. Scholz J, Finnerup NB, Attal N, Aziz Q, Baron R, Bennett MI, et al. The IASP classification of chronic pain for ICD-11: chronic neuropathic pain. Pain. 2019;160(1):53-9.
5. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211.
6. Freynhagen R, Wirz S, Rolke R. [Diagnosis of neuropathic pain]. Ther Umsch. 2011;68(9):495-500.
7. Gracely RH, Lynch SA, Bennett GJ. Painful neuropathy: altered central processing maintained dynamically by peripheral input. Pain. 1992;51(2):175-94.
8. Mishra S, Bhatnagar S, Goyal GN, Rana SP, Upadhya SP. A comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: a prospective randomized double-blind placebo-controlled study. Am J Hosp Palliat Care. 2012;29(3):177-82.
9. Zakrzewska JM, McMillan R. Trigeminal neuralgia: the diagnosis and management of this excruciating and poorly understood facial pain. Postgrad Med J. 2011;87(1028):410-6.
10. Sindrup SH, Otto M, Finnerup NB, Jensen TS. Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol. 2005;96(6):399-409.
11. Gilron I, Max MB. Combination pharmacotherapy for neuropathic pain: current evidence and future directions. Expert Rev Neurother. 2005;5(6):823-30.